I wrote this article for @Mergermarket about M&A in the mental health space area. Check it out for some interesting insights 🔍
https://t.co/AalFMuj8EI
Akili, which makes an FDA-cleared video game to treat ADHD, just dropped its regulatory filing as it prepares to go public via SPAC merger
https://t.co/OptskE3iKb
#2 is from @MaxGelman
UPDATED: FDA advisors recommend against approving Eli Lilly’s PD-1, casting shadow over future of China-made cancer drugs
https://t.co/z4VcLJcXAg
@CrisprMedicine@umnmedschool Early, but quite an interesting idea to disrupt these receptors with base editing and thus avoiding all of the risks associated with DSBs for the patients.
@patrick_oshag@joincolossus Big picture one - how biotech has been moving from serendipitous discoveries to engineering (incl. gene editing, mRNA, Car-Ts, TPD, etc.). Perhaps someone with broad expertise in the industry - @Evotec or AI names (@Schrodinger, @RecursionPharma or @exscientiaAI)?
@KarenAiach: after her child was diagnosed with MPS IIIA, she founded a company seeking treatment. Just awarded business woman of the year! https://t.co/sEaFRcRejs